More Large Employers Turning To Specialty Drug “Carve Out” In 2014 – Survey
The annual Towers Watson/National Business Group on Health survey, which tracks employers’ strategies and practices for managing health benefits for their workers, included questions on how they are handling specialty drug costs.
You may also be interested in...
Letter from department’s general counsel responds to request from the company for a pre-enforcement advisory opinion. Despite the letter, Lilly maintains its ‘limited distribution program is fully consistent with applicable laws and regulations.’
Center for American Progress suggests pricing reforms for the 'next Administration' in lieu of legislation.
Effectiveness can be evaluated more quickly because researchers won’t have to wait for the second dose, company executive notes during briefing on the launch of the Phase III study.